We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
- Authors
Winer, Eric P; Hudis, Clifford; Burstein, Harold J; Chlebowski, Rowan T; Ingle, James N; Edge, Stephen B; Mamounas, Eleftherios P; Gralow, Julie; Goldstein, Lori J; Pritchard, Kathleen I; Braun, Susan; Cobleigh, Melody A; Langer, Amy S; Perotti, Judy; Powles, Trevor J; Whelan, Timothy J; Browman, George P
- Abstract
To conduct an evidence-based technology assessment to determine whether the routine use of anastrozole or any of the aromatase inhibitors in the adjuvant breast cancer setting is appropriate for broad-based conventional use in clinical practice. POTENTIAL INTERVENTIONS: Anastrozole, letrozole, and exemestane.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Vol 20, Issue 15, p3317
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2002.06.020